Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700022700

Trial Profile

Clinical Trials Insight: 700022700

Phase of Trial: Phase I

Latest Information Update: 09 Feb 2010

At a glance

  • Drugs Laninamivir (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza A virus H9N2 subtype; Influenza B virus infections
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 09 Feb 2010 Results published in the Journal of Clinical Pharmacology.
    • 24 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top